Skip to content

A New Frontier in CWD Detection: Antemortem Plasma Biomarkers and Behavioral Profiling in Transgenic Mouse Models

Aug 2026 · bioRxiv · 0 citations · 69 references
Biology

TL;DR

This is the first demonstration that these three plasma biomarkers are useful not only for detecting CWD, but also for identifying it at early antemortem stages of disease, to enable earlier detection and assist with disease management.

View source

Similar papers

Review Open access Aug 2026

Advances in biomarker discovery for canine cognitive dysfunction: a comprehensive structured narrative review and future perspectives

Overall, the CCD biomarker landscape supports a multimodal approach integrating Aβ dysregulation, axonal injury, and glial activation, which will strengthen the translational value of CCD as a model for human dementia, accelerating discovery and therapeutic development across species.

Klysse Assumpção Barbosa, Heloísa Máximo Ribeiro, L. Benevenuto et al. · 0 citations
Open access Jul 2026

Identification and initial characterization of novel prion protein gene (PRNP) variants in wild Montana mule deer

This study reports the sequencing of the prion protein gene (PRNP) in retropharyngeal lymph node samples from 358 Montana mule deer and the identification of 36 PRNP genetic variants, many of which have not been reported previously.

Alyssa L. Seerley, Mike T. Rothfuss, Bridget M. Gray et al. · 1 citation
Open access Jul 2026

A Comparative Study of Plasma Biomarkers of Neurodegeneration in Rhesus Monkeys (Macaca mulatta) and Baboons (Papio anubis)

This is the first systematic comparative study of age-related changes in neurodegeneration biomarkers in two closely related nonhuman primates using comparable age ranges and sample sizes, and the same multiplex assay.

M. M. Mulholland, Elizabeth R. Magden, H. Scholtzova et al. · 0 citations
Review Open access Aug 2026

Tracing neuroinflammation in neurodegeneration: insights from a scoping review on biofluid biomarkers

A scoping review of neuroinflammation biomarkers across major neurodegenerative diseases covering the past 23 years found a subset of markers, including NLR, YKL-40 and GFAP, shows relatively consistent associations and may warrant further investigation across diseases.

Nadine A. van de Zande, Charlotte C C Ruiter, Myrthe A Polman et al. · 0 citations
Review Open access Aug 2026

Mechanisms, Biomarkers and Therapeutic Implications of Neuroinflammation in Alzheimer's Disease

The dual and stage‐dependent roles of microglia and astrocytes are explored, discussion of blood–brain barrier dysfunction and peripheral immune infiltration as underappreciated pathogenic contributors are expanded, and emerging evidence linking neuroinflammation specifically to tau pathology is integrated.

S. Papelian · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.